New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
07:26 EDTMNKMallinckrodt price hike likely to see little resistance, says Leerink
Leerink said its channel checks indicate Mallinckrodt's Ofirmev price increase is likely to face minimal resistance. The firm raised its price target for shares to $90 from $82 and keeps a Market Perform rating on the name.
News For MNK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 9, 2014
14:22 EDTMNKAetna updates clinical policy for H.P. Acthar Gel
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use